Clinical Monitoring Intern (Summer 2027)
Medpace, Inc.
Summary
Medpace is seeking full-time Clinical Monitoring Interns to join our team for Summer 2027. This summer internship will provide you with insight on the day-to-day responsibilities of our Clinical Monitoring team. You will also receive hands on training and support various projects within Clinical Operations. This internship will be fully office-based in Cincinnati, OH.
Job description
Responsibilities
- Become familiar with ICH-GCP guidelines, industry regulations, and Medpace systems
- Support Clinical Monitoring team in conducting clinical site activities
- Provide day-to-day departmental and project support
- Observe CRA PACE® training sessions
- Conduct quality control of documents
- Maintain spreadsheets and compile reports
Qualifications
- Working towards a Bachelor’s degree in a Life Science related field, with expected graduation in Fall 2027 or Spring 2028
- Local to Cincinnati, OH and or the surrounding area
- Excellent organizational, communication, and prioritization skills
- Knowledge of Microsoft Office
Requirements
- Working towards a Bachelor’s degree in a Life Science related field
- Expected graduation in Fall 2027 or Spring 2028
- Local to Cincinnati, OH and/or the surrounding area
- Excellent organizational, communication, and prioritization skills
- Knowledge of Microsoft Office
Benefits
- Health Insurance
- Wellness Programs
- Retirement Benefits
- Paid Time Off
- On-site Dining
- On-site Fitness Facilities
- Free Parking
Company overview
Medpace Holdings, Inc. is a global full-service clinical contract research organization (CRO) headquartered in Cincinnati, Ohio, founded in 1992. The company provides comprehensive Phase I-IV clinical development services to biotechnology, pharmaceutical, and medical device industries worldwide. With over 30 years of experience, Medpace employs a scientifically-driven approach that integrates medical, operational, and regulatory expertise across all major therapeutic areas including oncology, cardiology, metabolic diseases, endocrinology, central nervous system disorders, and infectious diseases. The company operates a unique full-service model that includes wholly-owned central laboratories, bioanalytical laboratories, imaging core labs, ECG core labs, and a Phase I clinical unit, all integrated to streamline clinical trial execution. Medpace's global presence spans North America, Europe, Asia Pacific, and Latin America, with approximately 6,000 employees across 44 countries. The company went public in 2016 and trades on NASDAQ under the symbol MEDP, consistently demonstrating strong growth while maintaining its focus on accelerating the development of safe and effective medical therapeutics through high-quality clinical research services.